Cervical HPV infection in Guangzhou, China: an epidemiological study of 198,111 women from 2015 to 2021

References

• Sung H, Ferlay J, Siegel R L, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries [J]. CA Cancer J Clin. 2021;71 (3):209–249.
   PubMed Web of Science ®Google Scholar
• Arbyn M, Weiderpass E, Bruni L, et al. Estimates of incidence and mortality of cervical cancer in 2018: a worldwide analysis [J]. Lancet Glob Health. 2020;8 (2):e191–e203.
   PubMed Web of Science ®Google Scholar
• World Health Organization. Electronic address s w i. Human papillomavirus vaccines: WHO position paper, May 2017-Recommendations [J]. Vaccine. 2017;35 (43):5753–5755.
   PubMed Web of Science ®Google Scholar
• Soto D, Song C, McLaughlin-Drubin ME. Epigenetic Alterations in Human Papillomavirus-Associated Cancers [J]. Viruses. 2017;9 (9):248.
   PubMed Web of Science ®Google Scholar
• Humans I W G o t E o C R t. Human papillomaviruses [J]. IARC Monogr Eval Carcinog Risks Hum. 2007;90:1–636.
   PubMedGoogle Scholar
• de Sanjose S, Quint W G, Alemany L, et al. Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study [J]. Lancet Oncol. 2010;11 (11):1048–1056.
   PubMed Web of Science ®Google Scholar
• Crosbie E J, Einstein M H, Franceschi S, et al. Human papillomavirus and cervical cancer [J]. Lancet. 2013;382 (9895):889–899.
   PubMed Web of Science ®Google Scholar
• Tumban E. A Current Update on Human Papillomavirus-Associated Head and Neck Cancers [J]. Viruses. 2019;11 (10):922.
   PubMed Web of Science ®Google Scholar
• Karnosky J, Dietmaier W, Knuettel H, et al. HPV and lung cancer: A systematic review and meta-analysis [J]. Cancer Rep (Hoboken). 2021;4 (4):e1350.
   PubMedGoogle Scholar
• Joura E A, Giuliano A R, Iversen O E, et al. A 9-valent HPV vaccine against infection and intraepithelial neoplasia in women [J]. N Engl J Med. 2015;372 (8):711–723.
   PubMed Web of Science ®Google Scholar
• Arbyn M, Ronco G, Anttila A, et al. Evidence regarding human papillomavirus testing in secondary prevention of cervical cancer [J]. Vaccine. 2012;30 (suppl 5):F88–F99.
   PubMed Web of Science ®Google Scholar
• Ronco G, Dillner J, Elfstrom K M, et al. Efficacy of HPV-based screening for prevention of invasive cervical cancer: follow-up of four European randomised controlled trials [J]. Lancet. 2014;383 (9916):524–532.
   PubMed Web of Science ®Google Scholar
• WHO guidelines for the use of thermal ablation for cervical pre-cancer lesions. Geneva; World Health Organization. 2019. https://www.ncbi.nlm.nih.gov/books/NBK549182/
   Google Scholar
• Li K, Yin R, Li Q, et al. Analysis of HPV distribution in patients with cervical precancerous lesions in Western China [J]. Medicine (Baltimore). 2017;96 (29):e7304.
   PubMed Web of Science ®Google Scholar
• Bruni L, Diaz M, Castellsague X, et al. Cervical human papillomavirus prevalence in 5 continents: meta-analysis of 1 million women with normal cytological findings [J]. J Infect Dis. 2010;202 (12):1789–1799.
   PubMed Web of Science ®Google Scholar
• de Sanjosé S, Diaz M, Castellsagué X, et al. Worldwide prevalence and genotype distribution of cervical human papillomavirus DNA in women with normal cytology: a meta-analysis [J]. Lancet Infect Dis. 2007;7 (7):453–459.
   PubMed Web of Science ®Google Scholar
• Long W, Yang Z, Li X, et al. HPV-16, HPV-58, and HPV-33 are the most carcinogenic HPV genotypes in Southwestern China and their viral loads are associated with severity of premalignant lesions in the cervix [J]. Virol J. 2018;15 (1):94.
   PubMedGoogle Scholar
• Nayar R, Wilbur DC. The Pap test and Bethesda 2014 [J]. Cancer Cytopathol. 2015;123 (5):271–281.
   PubMed Web of Science ®Google Scholar
• Low H C, Silver M I, Brown B J, et al. Comparison of Hybribio GenoArray and Roche human papillomavirus (HPV) linear array for HPV genotyping in anal swab samples [J]. J Clin Microbiol. 2015;53 (2):550–556.
   PubMed Web of Science ®Google Scholar
• Wang X, Ji Y, Li J, et al. Prevalence of human papillomavirus infection in women in the Autonomous Region of Inner Mongolia: A population-based study of a Chinese ethnic minority [J]. J Med Virol. 2018;90 (1):148–156.
   PubMed Web of Science ®Google Scholar
• Wang R, Guo X L, Wisman G B, et al. Nationwide prevalence of human papillomavirus infection and viral genotype distribution in 37 cities in China [J]. BMC Infect Dis. 2015;15:257.
   PubMed Web of Science ®Google Scholar
• Mai Q, Yang X, Cheng H, et al. Prevalence and genotype distribution of human papillomavirus among women with cervical lesions in Shenzhen city, China [J]. Hum Vaccin Immunother. 2021;17 (4):965–971.
   PubMed Web of Science ®Google Scholar
• Li J, Gao J J, Li N, et al. Distribution of human papillomavirus genotypes in western China and their association with cervical cancer and precancerous lesions [J]. Arch Virol. 2021;166 (3):853–862.
   PubMed Web of Science ®Google Scholar
• Jing L, Zhong X, Zhong Z, et al. Prevalence of human papillomavirus infection in Guangdong Province, China: a population-based survey of 78,355 women [J]. Sex Transm Dis. 2014;41 (12):732–738.
   PubMed Web of Science ®Google Scholar
• Clifford G M, Smith J S, Plummer M, et al. Human papillomavirus types in invasive cervical cancer worldwide: a meta-analysis [J]. Br J Cancer. 2003;88 (1):63–73.
   PubMed Web of Science ®Google Scholar
• Walboomers J MM, Jacobs M V, Manos M M, et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide [J]. J Pathol. 1999;189 (1):12–19.
   PubMed Web of Science ®Google Scholar
• Zhang L, Bi Q, Deng H, et al. Human papillomavirus infections among women with cervical lesions and cervical cancer in Eastern China: genotype-specific prevalence and attribution [J]. BMC Infect Dis. 2017;17 (1):107.
   PubMedGoogle Scholar
• Yao L, Yuan M, Yuan J, et al. Analysis of cervical human papillomavirus infection in 2300 women in Urumqi, China [J]. Medicine (Baltimore. 2018;97 (45):e13206.
   PubMed Web of Science ®Google Scholar
• Zhu X, Wang Y, Lv Z, et al. Prevalence and genotype distribution of high-risk HPV infection among women in Beijing, China [J]. J Med Virol. 2021;93 (8):5103–5109.
   PubMed Web of Science ®Google Scholar
• Clifford G M, Smith J S, Aguado T, et al. Comparison of HPV type distribution in high-grade cervical lesions and cervical cancer: a meta-analysis [J]. Br J Cancer. 2003;89 (1):101–105.
   PubMed Web of Science ®Google Scholar
• Munoz N, Bosch F X, de Sanjose S, et al. Epidemiologic classification of human papillomavirus types associated with cervical cancer [J]. N Engl J Med. 2003;348 (6):518–527.
   PubMed Web of Science ®Google Scholar
• Castellsague X, Diaz M, de Sanjose S, et al. Worldwide human papillomavirus etiology of cervical adenocarcinoma and its cofactors: implications for screening and prevention [J]. J Natl Cancer Inst. 2006;98 (5):303–315.
   PubMed Web of Science ®Google Scholar
• Xiang F, Guan Q, Liu X, et al. Distribution characteristics of different human papillomavirus genotypes in women in Wuhan, China [J]. J Clin Lab Anal. 2018;32 (8):e22581.
   PubMed Web of Science ®Google Scholar
• Moscicki A B, Hills N, Shiboski S, et al. Risks for incident human papillomavirus infection and low-grade squamous intraepithelial lesion development in young females [J]. JAMA. 2001;285 (23):2995–3002.
   PubMed Web of Science ®Google Scholar
• Ma Y, Wang C, Liu F, et al. Human papillomavirus vaccination coverage and knowledge, perceptions and influencing factors among university students in Guangzhou, China [J]. Hum Vaccin Immunother. 2021;17 (10):3603–3612.
   PubMed Web of Science ®Google Scholar
• Franceschi S, Herrero R, Clifford G M, et al. Variations in the age-specific curves of human papillomavirus prevalence in women worldwide [J]. Int J Cancer. 2006;119 (11):2677–2684.
   PubMed Web of Science ®Google Scholar
• Sichero L, Ferreira S, Trottier H, et al. High grade cervical lesions are caused preferentially by non-European variants of HPVs 16 and 18 [J]. Int J Cancer. 2007;120 (8):1763–1768.
   PubMed Web of Science ®Google Scholar
• Schiffman M. Integration of human papillomavirus vaccination, cytology, and human papillomavirus testing [J]. Cancer. 2007;111 (3):145–153.
   PubMed Web of Science ®Google Scholar
• Moscicki A B, Schiffman M, Burchell A, et al. Updating the natural history of human papillomavirus and anogenital cancers [J]. Vaccine. 2012;30 (suppl 5):F24–F33.
   PubMedGoogle Scholar
• Plummer M, Schiffman M, Castle P E, et al. A 2-year prospective study of human papillomavirus persistence among women with a cytological diagnosis of atypical squamous cells of undetermined significance or low-grade squamous intraepithelial lesion [J]. J Infect Dis. 2007;195 (11):1582–1589.
   PubMed Web of Science ®Google Scholar
• Rodriguez A C, Schiffman M, Herrero R, et al. Rapid clearance of human papillomavirus and implications for clinical focus on persistent infections [J]. J Natl Cancer Inst. 2008;100 (7):513–517.
   PubMedGoogle Scholar
• Schiffman M, Herrero R, Desalle R, et al. The carcinogenicity of human papillomavirus types reflects viral evolution [J]. Virology. 2005;337 (1):76–84.
   PubMed Web of Science ®Google Scholar
• Leonard B, Kridelka F, Delbecque K, et al. A clinical and pathological overview of vulvar condyloma acuminatum, intraepithelial neoplasia, and squamous cell carcinoma [J]. Biomed Res Int. 2014;2014:480573.
   PubMed Web of Science ®Google Scholar
• Gupta G, Glueck R, Patel P R. HPV vaccines: Global perspectives [J]. Hum Vaccin Immunother. 2017;13 (6):1–4.
   PubMed Web of Science ®Google Scholar
• Wolday D, Derese M, Gebressellassie S, et al. HPV genotype distribution among women with normal and abnormal cervical cytology presenting in a tertiary gynecology referral Clinic in Ethiopia [J]. Infect Agent Cancer. 2018;13:28.
   PubMed Web of Science ®Google Scholar
• Wei F, Yin K, Wu X, et al. Human papillomavirus prevalence and associated factors in women and men in south China: a population-based study [J]. Emerg Microbes Infect. 2016;5 (11):e119.
   PubMedGoogle Scholar